Source: International Journal of Pharmaceutics. Unidades: ICB, IQ
Subjects: FARMACOLOGIA, LIPÍDEOS, POLÍMEROS (QUÍMICA ORGÂNICA), POLÍMEROS (MATERIAIS), NEOPLASIAS COLORRETAIS, QUIMIOTERAPIA, ANTI-INFLAMATÓRIOS, CITOTOXICIDADE IMUNOLÓGICA, CITOESQUELETO, GLICOPEPTÍDEOS
ABNT
FUKUMORI, Claudio et al. Polymer-lipid hybrid microcarriers for oral codelivery of paclitaxel and tributyrin: development, optimization, and cytotoxicity in cells and spheroids of colorectal cancer. International Journal of Pharmaceutics, v. 676, p. 15 , 2025Tradução . . Disponível em: https://doi.org/10.1016/j.ijpharm.2025.125549. Acesso em: 20 maio 2025.APA
Fukumori, C., Kawassaki, R. K., Daré, R. G., & Lopes, L. B. (2025). Polymer-lipid hybrid microcarriers for oral codelivery of paclitaxel and tributyrin: development, optimization, and cytotoxicity in cells and spheroids of colorectal cancer. International Journal of Pharmaceutics, 676, 15 . doi:10.1016/j.ijpharm.2025.125549NLM
Fukumori C, Kawassaki RK, Daré RG, Lopes LB. Polymer-lipid hybrid microcarriers for oral codelivery of paclitaxel and tributyrin: development, optimization, and cytotoxicity in cells and spheroids of colorectal cancer [Internet]. International Journal of Pharmaceutics. 2025 ; 676 15 .[citado 2025 maio 20 ] Available from: https://doi.org/10.1016/j.ijpharm.2025.125549Vancouver
Fukumori C, Kawassaki RK, Daré RG, Lopes LB. Polymer-lipid hybrid microcarriers for oral codelivery of paclitaxel and tributyrin: development, optimization, and cytotoxicity in cells and spheroids of colorectal cancer [Internet]. International Journal of Pharmaceutics. 2025 ; 676 15 .[citado 2025 maio 20 ] Available from: https://doi.org/10.1016/j.ijpharm.2025.125549